3/A

OWNERSHIP DOCUMENT

Company: Quoin Pharmaceuticals, Ltd.
Filed: March 7, 2023
Period of Report: January 1, 2023
Accession Number: 0001104659-23-029715

View Document ↗ View on SEC.gov ↗